Skip to content
ppharmaranks
Menu

GLEEVEC vs SIROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. GLEEVEC and SIROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

70/100
66/100

Pharmacy pays

~$25.80 /30
~$48.61 /30

Type

RX
RX

Active ingredient

IMATINIB MESYLATE
SIROLIMUS

Manufacturer

Dosage forms

Tablet
Solution

Drug class

Kinase Inhibitor
Kinase Inhibitor

Boxed warning

Treats

Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome
Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

Which is better-rated, Gleevec or Sirolimus?

By our independent rating, Gleevec scores higher — 3.5 vs 3.3 out of 5 for Sirolimus. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Gleevec or Sirolimus?

Gleevec costs pharmacies less to acquire — about $25.80 vs $48.61 for a 30-count supply, per the CMS NADAC survey. That gap is in the pharmacy's cost of goods, not necessarily in what you pay: your price is set afterwards by your insurer and the pharmacy.

What is the difference between Gleevec and Sirolimus?

Gleevec contains Imatinib Mesylate, while Sirolimus contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.